Safety and Occupational Health Study Section (SOHSS), National Institute for Occupational Safety and Health (NIOSH), 5198 [E8-1458]
Download as PDF
<![CDATA[
5198
Federal Register / Vol. 73, No. 19 / Tuesday, January 29, 2008 / Notices
Nelson Auditorium, Atlanta, Georgia
30333.
Status: Open to the public, limited
only by the space available.
Purpose: The committee is charged
with advising the Director, CDC, on the
appropriate uses of immunizing agents.
In addition, under 42 U.S.C.1396s, the
committee is mandated to establish and
periodically review and, as appropriate,
revise the list of vaccines for
administration to vaccine-eligible
children through the Vaccines for
Children (VFC) program, along with
schedules regarding the appropriate
periodicity, dosage, and
contraindications applicable to the
vaccines.
Matters To Be Discussed: The agenda
will include discussions on Influenza
Vaccines; Meningococcal Conjugate
Vaccine; Rabies Vaccine and
Biologicals; Human Papillomavirus
Vaccines; Anthrax Vaccine; Rotavirus
Vaccines; Use of Vaccines during
Pregnancy & Breastfeeding; Update on
Vaccine Supply; General
Recommendations; Japanese
Encephalitis Vaccines; Immunization
Safety Update; Combination Vaccines;
Update on Implementation of Approach
to Economic Analyses and agency
updates. There may be VFC voting on
the Influenza and Meningococcal
Vaccines.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Antonette Hill, Immunization Services
Division, National Center for
Immunization and Respiratory Diseases,
CDC, 1600 Clifton Road, NE., Mailstop
E–05, Atlanta, Georgia 30333,
Telephone (404) 639–8836, Fax (404)
639–8905.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the CDC
and ATSDR.
sroberts on PROD1PC70 with NOTICES
Dated: January 18, 2008.
Diane Allen,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E8–1457 Filed 1–28–08; 8:45 am]
BILLING CODE 4160–18–P
VerDate Aug<31>2005
22:52 Jan 28, 2008
Jkt 214001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Safety and Occupational Health Study
Section (SOHSS), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following Meeting for the
aforementioned committee:
Times and Dates: 8 a.m.–5 p.m.,
February 19, 2008 (Closed); 8 a.m.–5
p.m., February 20, 2008 (Closed)
Place: Sir Francis Drake Hotel, 450
Powell Street, San Francisco, California
94102, Telephone (415) 392–7755, Fax
(415) 391–8719.
Purpose: The Safety and Occupational
Health Study Section will review,
discuss, and evaluate grant
application(s) received in response to
the Institute’s standard grants review
and funding cycles pertaining to
research issues in occupational safety
and health, and allied areas.
It is the intent of NIOSH to support
broad-based research endeavors in
keeping with the Institute’s program
goals. This will lead to improved
understanding and appreciation for the
magnitude of the aggregate health
burden associated with occupational
injuries and illnesses, as well as to
support more focused research projects,
which will lead to improvements in the
delivery of occupational safety and
health services, and the prevention of
work-related injury and illness. It is
anticipated that research funded will
promote these program goals.
Matters To Be Discussed: The meeting
will convene to address matters related
to the conduct of Study Section
business and for the study section to
consider safety and occupational healthrelated grant applications. These
portions of the meeting will be closed to
the public in accordance with
provisions set forth in section 552b(c)(4)
and (6), Title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, Centers for Disease Control and
Prevention, pursuant to section 10(d)
Public Law 92–463.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Price Connor, PhD., NIOSH Health
Scientist, 1600 Clifton Road, NE.,
Mailstop E–20, Atlanta, Georgia 30333,
Telephone (404)498–2511, Fax
(404)498–2571.
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both CDC and
the Agency for Toxic Substances and
Disease Registry.
Dated: January 19, 2008.
Diane Allen,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E8–1458 Filed 1–28–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Statement of Organization, Functions
and Delegation of Authority
Notice is hereby given that I have
delegated to the Director, Office of
Refugee Resettlement, with the
authority to further re-delegate, the
following authority delegated to the
Assistant Secretary for Children and
Families by the Secretary of the
Department of Health and Human
Services on April 30, 2004.
(a) Authority Delegated.
Authority to conduct public
awareness and information activities
under the Trafficking Victims Protection
Act of 2000 (TVPA), Public Law 106–
386, section 106(b), 22 U.S.C. 7104(b).
(b) Limitations and Conditions.
1. This delegation shall be exercised
under the Department’s existing
delegation of authority and policy on
regulations.
2. This delegation shall be exercised
under financial and administrative
requirements applicable to all
Administration for Children and
Families’ authorities.
3. The Director of the Anti-Trafficking
in Persons Division must report to the
Director, Office of Refugee Resettlement,
and the Director, Office of Refugee
Resettlement, must report to the
Assistant Secretary prior to carrying out
public awareness and information
activities.
(c) Effective Date.
This delegation is effective upon date
of signature.
(d) Effect on Existing Delegations.
None.
In addition, I have affirmed and
ratified any actions taken by the
Director, Office of Refugee Resettlement,
which involved the exercise of this
authority prior to the effective date of
this delegation.
E:\FR\FM\29JAN1.SGM
29JAN1
]]>Agencies
[Federal Register Volume 73, Number 19 (Tuesday, January 29, 2008)]
[Notices]
[Page 5198]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-1458]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Safety and Occupational Health Study Section (SOHSS), National
Institute for Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following Meeting for the aforementioned
committee:
Times and Dates: 8 a.m.-5 p.m., February 19, 2008 (Closed); 8 a.m.-
5 p.m., February 20, 2008 (Closed)
Place: Sir Francis Drake Hotel, 450 Powell Street, San Francisco,
California 94102, Telephone (415) 392-7755, Fax (415) 391-8719.
Purpose: The Safety and Occupational Health Study Section will
review, discuss, and evaluate grant application(s) received in response
to the Institute's standard grants review and funding cycles pertaining
to research issues in occupational safety and health, and allied areas.
It is the intent of NIOSH to support broad-based research endeavors
in keeping with the Institute's program goals. This will lead to
improved understanding and appreciation for the magnitude of the
aggregate health burden associated with occupational injuries and
illnesses, as well as to support more focused research projects, which
will lead to improvements in the delivery of occupational safety and
health services, and the prevention of work-related injury and illness.
It is anticipated that research funded will promote these program
goals.
Matters To Be Discussed: The meeting will convene to address
matters related to the conduct of Study Section business and for the
study section to consider safety and occupational health-related grant
applications. These portions of the meeting will be closed to the
public in accordance with provisions set forth in section 552b(c)(4)
and (6), Title 5 U.S.C., and the Determination of the Director,
Management Analysis and Services Office, Centers for Disease Control
and Prevention, pursuant to section 10(d) Public Law 92-463.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Price Connor, PhD., NIOSH
Health Scientist, 1600 Clifton Road, NE., Mailstop E-20, Atlanta,
Georgia 30333, Telephone (404)498-2511, Fax (404)498-2571.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: January 19, 2008.
Diane Allen,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. E8-1458 Filed 1-28-08; 8:45 am]
BILLING CODE 4163-18-P
